From DecrIPt's Inception Till Today
- 2003-2005: The French PTO (INPI), in collaboration with Pfizer developed the capability for random enumeration of Markush Structures using INPI-Questel MMS database.
- 2005: INPI terminated the collaboration with Pfizer and suggested the creation of an independent company for continuing the software development.
- 2006: Creation of DecrIPt LLC.
- 2007: Creation of DecrIPt Inc.
- 2007: DecrIPt Inc. and QUESTEL explore feasibility of enumerating the MMS database.
- 2008 Testing of the enumeration capability of the MMS data base and initiation of product marketing.
